Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
Aptamers are short sequences of nucleic acid (DNA or RNA) or peptide molecules which adopt a conformation and bind cognate ligands with high affinity and specificity in a manner akin to antibody-antigen interactions. It has been globally acknowledged that aptamers promise a plethora of diagnostic an...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/540451 |
id |
doaj-eb469542ef2b4ab99d9d57e4d04daf02 |
---|---|
record_format |
Article |
spelling |
doaj-eb469542ef2b4ab99d9d57e4d04daf022020-11-24T23:05:21ZengHindawi LimitedBioMed Research International2314-61332314-61412014-01-01201410.1155/2014/540451540451Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and TherapeuticsBaby Santosh0Pramod K. Yadava1Applied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, IndiaApplied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, IndiaAptamers are short sequences of nucleic acid (DNA or RNA) or peptide molecules which adopt a conformation and bind cognate ligands with high affinity and specificity in a manner akin to antibody-antigen interactions. It has been globally acknowledged that aptamers promise a plethora of diagnostic and therapeutic applications. Although use of nucleic acid aptamers as targeted therapeutics or mediators of targeted drug delivery is a relatively new avenue of research, one aptamer-based drug “Macugen” is FDA approved and a series of aptamer-based drugs are in clinical pipelines. The present review discusses the aspects of design, unique properties, applications, and development of different aptamers to aid in cancer diagnosis, prevention, and/or treatment under defined conditions.http://dx.doi.org/10.1155/2014/540451 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Baby Santosh Pramod K. Yadava |
spellingShingle |
Baby Santosh Pramod K. Yadava Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics BioMed Research International |
author_facet |
Baby Santosh Pramod K. Yadava |
author_sort |
Baby Santosh |
title |
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics |
title_short |
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics |
title_full |
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics |
title_fullStr |
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics |
title_full_unstemmed |
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics |
title_sort |
nucleic acid aptamers: research tools in disease diagnostics and therapeutics |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2014-01-01 |
description |
Aptamers are short sequences of nucleic acid (DNA or RNA) or peptide molecules which adopt a conformation and bind cognate ligands with high affinity and specificity in a manner akin to antibody-antigen interactions. It has been globally acknowledged that aptamers promise a plethora of diagnostic and therapeutic applications. Although use of nucleic acid aptamers as targeted therapeutics or mediators of targeted drug delivery is a relatively new avenue of research, one aptamer-based drug “Macugen” is FDA approved and a series of aptamer-based drugs are in clinical pipelines. The present review discusses the aspects of design, unique properties, applications, and development of different aptamers to aid in cancer diagnosis, prevention, and/or treatment under defined conditions. |
url |
http://dx.doi.org/10.1155/2014/540451 |
work_keys_str_mv |
AT babysantosh nucleicacidaptamersresearchtoolsindiseasediagnosticsandtherapeutics AT pramodkyadava nucleicacidaptamersresearchtoolsindiseasediagnosticsandtherapeutics |
_version_ |
1725626089447882752 |